Sclerosing encapsulating peritonitis secondary to CAPD: the effect of fibrotic debridement on further dialysis

被引:0
作者
Klimopoulos, S
Katsoulis, IE
Margellos, V
Nikolopoulou, N
机构
[1] Evangelismos Gen Hosp, Dept Surg 2, Athens 10676, Greece
[2] Evangelismos Gen Hosp, Dept Nephrol, Athens 10676, Greece
来源
JOURNAL OF THE ROYAL COLLEGE OF SURGEONS OF EDINBURGH | 2002年 / 47卷 / 02期
关键词
sclerosing peritonitis; sclerosing-encapsulating peritonitis; peritoneal dialysis;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Sclerosing peritonitis (SCP) is a complication of continuous ambulatory peritoneal dialysis (CAPD) and is characterized by progressive fibrosis of the peritoneum. Entrapment of the intestine in a fibrous sac resulting in complete intestinal obstruction is called sclerosing-encapsulating peritonitis (SEP) and represents the most severe form of the disease. Various reports have been pessimistic regarding the surgical outcome when SEP has caused complete intestinal obstruction. Continuation of CAPD after laparotomy is generally considered not feasible. The aim of this article is to present our experience in the surgical management of SEP and, in particular, in the postoperative continuation of CAPD. Material and Methods: Seventeen consecutive patients with SCP among 175 patients undergoing CAPD during a period of 14 years in a single Unit were retrospectively reviewed. Two groups of patients were recognized. The SCP group included 9 patients with incomplete intestinal obstruction that were treated with single peritoneal catheter removal and switching to haemodialysis. The SEP group included 8 patients with complete obstruction that necessitated laparotomy for surgical debridement of the fibrotic tissue and release of the intestinal loops. Results: Switching to haemodialysis improved the majority of the group of patients. In 2 of the SEP group of patients (early in the series), where enterectomy was inevitable, performance of an intestinal anastomosis resulted in leakage with subsequent fatal outcome. Two of the SEP group of patients were transferred to haemodialysis after the laparotomy. In the remaining 4 SEP patients (50%), exposure of a significant portion of active peritoneal surface was achieved - called "neoperitonization"-and allowed effective continuation of peritoneal dialysis for an average duration of 16 months (range 1-32). Conclusions: In patients with SEP, careful release of the intestinal loops avoiding enterectomies and even inadvertent intestinal wounds is mandatory. Continuation of peritoneal dialysis after meticulous debridement and removal of the fibrotic tissue is possible and may be effective. To the best of our knowledge, there have not been previously reported cases of continuations of CAPD after laparotomy for SEP.
引用
收藏
页码:485 / 490
页数:6
相关论文
共 19 条
  • [1] Sclerosing encapsulating peritonitis in a child secondary to peritoneal dialysis
    Tan, FLS
    Loh, D
    Prabhakaran, K
    JOURNAL OF PEDIATRIC SURGERY, 2005, 40 (05)
  • [2] Prognosis for patients with sclerosing encapsulating peritonitis following CAPD
    Yokota, S
    Kumano, K
    Sakai, T
    ADVANCES IN PERITONEAL DIALYSIS/1997, VOL 13: SELECTED PAPERS FROM THE SEVENTEENTH ANNUAL CONFERENCE ON PERITONEAL DIALYSIS, DENVER, COLORADO, FEBRUARY 1997, 1997, 13 : 221 - 223
  • [3] Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients
    Hoshii, S
    Honda, M
    Itami, N
    Oh, S
    Matsumura, C
    Moriya, S
    Mori, M
    Hatae, K
    Ito, Y
    Karashima, S
    PEDIATRIC NEPHROLOGY, 2000, 14 (04) : 275 - 279
  • [4] Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: A report of the Japanese Sclerosing Encapsulating Peritonitis Study Group
    Nomoto, Y
    Kawaguchi, Y
    Kubo, H
    Hirano, H
    Sakai, S
    Kurokawa, K
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (03) : 420 - 427
  • [5] Sclerosing encapsulating peritonitis in patients on long term peritoneal dialysis
    Liu, Meng-Lun
    Liu, Chi Ming
    Ho, Ai Sheng
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 275 - 276
  • [6] Sclerosing encapsulating peritonitis - Primary and secondary forms
    Cohen, O
    Abrahamson, J
    BenAri, J
    Frajewicky, V
    Eldar, S
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1996, 22 (01) : 54 - 57
  • [7] Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients
    S. Hoshii
    M. Honda
    N. Itami
    S. Oh
    C. Matsumura
    S. Moriya
    M. Mori
    K. Hatae
    Y. Ito
    S. Karashima
    Pediatric Nephrology, 2000, 14 : 275 - 279
  • [8] Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: Tamoxifen as a new therapeutic agent?
    Allaria, PM
    Giangrande, A
    Gandini, E
    Pisoni, IB
    JOURNAL OF NEPHROLOGY, 1999, 12 (06) : 395 - 397
  • [9] Pyloric outflow obstruction secondary to sclerosing encapsulating peritonitis in a dog
    Carroll, K. A.
    Wallace, M. L.
    Hill, T. L.
    Bartges, J. W.
    Ruby, J. L.
    Mulder, A. T., II
    Helmick, J. I.
    AUSTRALIAN VETERINARY JOURNAL, 2020, 98 (1-2) : 11 - 16
  • [10] Sclerosing encapsulating peritonitis associated with continuous ambulatory peritoneal dialysis: Surgical management
    Smith, L
    Collins, JF
    Morris, M
    Teele, RL
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (03) : 456 - 460